Stay updated on Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Sign up to get notified when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page

  1. Check
    yesterday
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.0 to v3.7.1 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-11T14:55:10.000Z thumbnail image
  2. Check
    8 days ago
    No Change Detected
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error page with its HTML markup, replacing the previous clinical trial content. Sponsor and trial-related sections and external links were removed, indicating the page is serving an error state rather than study details.
    Difference
    20%
    Check dated 2026-09-20T20:11:06.000Z thumbnail image
  5. Check
    43 days ago
    Change Detected
    Summary
    Two NIH grant/contract entries for 2017 and 2023 were added to the study record, expanding the funding metadata. The page revision tag was updated from v3.6.5 to v3.6.6 to reflect a newer version.
    Difference
    0.0%
    Check dated 2026-08-30T17:34:06.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.5, and the Plain Language Summary section and the older Revision: v3.6.4 have been removed. This reflects an updated version tag and a change in which content is displayed to users.
    Difference
    0.0%
    Check dated 2026-08-09T09:27:46.000Z thumbnail image
  7. Check
    72 days ago
    Change Detected
    Summary
    The Ukraine location entry in the Locations list was updated to use a different transliteration (Zaporizhzhya) from Zaporizhzhia. The old entry was removed and a new one added.
    Difference
    0.0%
    Check dated 2026-08-01T23:18:14.000Z thumbnail image
  8. Check
    79 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.3 to v3.6.4, signaling a newer version of the study detail page. This is a metadata change rather than a substantive update to the study content.
    Difference
    0.0%
    Check dated 2026-07-25T18:37:08.000Z thumbnail image

Stay in the know with updates to Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial.

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab in ER+/HER2- Breast Cancer Clinical Trial. page.